Francomano Robert
Chief Commercial Officer at STEMLINE THERAPEUTICS INC
- Sold, on record
- $72k
- Dollars the filings state
- Form 4 sales
- 4
- Latest May 4, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- STEMLINE THERAPEUTICS INCChief Commercial Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale STEMLINE THERAPEUTICS INCPlan not statedDec 27, 2019 2019
Sold 2,670 shares at $10.84 ($29k)
Francomano Robert, Chief Commercial Officer
Sold 2.6% of holdings ($1.1M position)98,321 shares leftFirst sale on recordFiling
- 2 Form 4 sale STEMLINE THERAPEUTICS INCPlan not statedFeb 7, 2020 +42 days
Sold 5,064 shares at $6.72 ($34k)
Francomano Robert, Chief Commercial Officer
Sold 5.2% of holdings ($661k position)93,257 shares leftFiling
- 3 Form 4 sale STEMLINE THERAPEUTICS INCPlan not statedMar 9, 2020 +31 days
Sold 1,266 shares at $5.00 ($6k)
Francomano Robert, Chief Commercial Officer
Sold 0.6% of holdings ($996k position)197,930 shares leftFiling
- 4 Form 4 sale STEMLINE THERAPEUTICS INCPlan not statedMay 4, 2020 +56 days
Sold 272 shares at $11.51 ($3k)
Francomano Robert, Chief Commercial Officer
Sold 0.1% of holdings ($2.3M position)197,658 shares left0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 4, 2020 | May 6, 2020 | STEMLINE THERAPEUTICS INC | Chief Commercial Officer | Form 4 sale | 272 | $3k | 0.1% | Plan not stated | SEC |
| Mar 9, 2020 | Mar 13, 2020 | STEMLINE THERAPEUTICS INC | Chief Commercial Officer | Form 4 sale | 1,266 | $6k | 0.6% | Plan not stated | SEC |
| Feb 7, 2020 | Feb 14, 2020 | STEMLINE THERAPEUTICS INC | Chief Commercial Officer | Form 4 sale | 5,064 | $34k | 5.2% | Plan not stated | SEC |
| Dec 27, 2019 | Jan 3, 2020 | STEMLINE THERAPEUTICS INC | Chief Commercial Officer | Form 4 sale | 2,670 | $29k | 2.6% | Plan not stated | SEC |